Lv11
10 积分 2023-10-25 加入
Current state and next-generation CAR-T cells in multiple myeloma
5小时前
已完结
Accelerating Accessibility of CAR-T/NK therapies – Are AlloCARs and rapid manufacturing platforms the road ahead in improving access in multiple myeloma?
5小时前
已完结
NK cell therapy in relapsed refractory multiple myeloma
5小时前
已完结
FT576: Multi-Specific Off-the-Shelf CAR-NK Cell Therapy Engineered for Enhanced Persistence, Avoidance of Self-Fratricide and Optimized Mab Combination Therapy to Prevent Antigenic Escape and Elicit a Deep and Durable Response in Multiple Myeloma
13小时前
已完结
FT576: Multi-Specific Off-the-Shelf CAR-NK Cell Therapy Engineered for Enhanced Persistence, Avoidance of Self-Fratricide and Optimized Mab Combination Therapy to Prevent Antigenic Escape and Elicit a Deep and Durable Response in Multiple Myeloma
13小时前
已关闭
CD70 CAR NK Cells in the Treatment of Multiple Myeloma
13小时前
求助中
Interim Phase I Clinical Data of FT576 As Monotherapy and in Combination with Daratumumab in Subjects with Relapsed/Refractory Multiple Myeloma
13小时前
已完结
Interim Phase I Clinical Data of FT576 As Monotherapy and in Combination with Daratumumab in Subjects with Relapsed/Refractory Multiple Myeloma
13小时前
已关闭
CD70 CAR NK Cells in the Treatment of Multiple Myeloma
13小时前
已关闭
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
14小时前
已完结
皖公网安备34019202002308
